These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 29985007)
21. In vivo effects of noradrenaline and noradrenergic receptor agonists and antagonists on rat cerebellar cyclic GMP levels. Haidamous M; Kouyoumdjian JC; Briley PA; Gonnard P Eur J Pharmacol; 1980 May; 63(4):287-94. PubMed ID: 6104602 [TBL] [Abstract][Full Text] [Related]
22. Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease. Kelm-Nelson CA; Brauer AF; Ciucci MR Behav Brain Res; 2016 Jul; 307():54-64. PubMed ID: 27025445 [TBL] [Abstract][Full Text] [Related]
23. Non-pharmacological induction of rat 50 kHz ultrasonic vocalization: Social and non-social contexts differentially induce 50 kHz call subtypes. Mulvihill KG; Brudzynski SM Physiol Behav; 2018 Nov; 196():200-207. PubMed ID: 30201573 [TBL] [Abstract][Full Text] [Related]
24. Effect of clonidine on ultrasonic vocalization in preweaning rats. Hård E; Engel J; Lindh AS J Neural Transm; 1988; 73(3):217-37. PubMed ID: 2905383 [TBL] [Abstract][Full Text] [Related]
25. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. Bond RA; Charlton KG; Clarke DE J Pharmacol Exp Ther; 1986 Feb; 236(2):408-15. PubMed ID: 2868118 [TBL] [Abstract][Full Text] [Related]
26. Meal pattern analysis of macronutrient intake after PVN norepinephrine and peripheral clonidine administration. Leibowitz SF; Shor-Posner G; Brennan G; Alexander JT Obes Res; 1993 Jan; 1(1):29-39. PubMed ID: 16353348 [TBL] [Abstract][Full Text] [Related]
27. Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations. Ringel LE; Basken JN; Grant LM; Ciucci MR Behav Brain Res; 2013 Sep; 252():252-9. PubMed ID: 23764460 [TBL] [Abstract][Full Text] [Related]
28. Noradrenergic terminals are the primary source of α Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147 [TBL] [Abstract][Full Text] [Related]
30. Norepinephrine release from spinal synaptosomes: auto-alpha2 -adrenergic receptor modulation. Li X; Zhao Z; Pan HL; Eisenach JC; Paqueron X Anesthesiology; 2000 Jul; 93(1):164-72. PubMed ID: 10861160 [TBL] [Abstract][Full Text] [Related]
31. Norepinephrine stimulates immunoreactive (ir) atrial natriuretic peptide (ANP) secretion and pro-ANP mRNA expression from rat hypothalamic neurons in culture: effects of alpha 2-adrenoceptors. Huang W; Lee D; Yang Z; Copolov DL; Lim AT Endocrinology; 1992 Apr; 130(4):2426-8. PubMed ID: 1312457 [TBL] [Abstract][Full Text] [Related]
32. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Curet O; de Montigny C Brain Res; 1988 Dec; 475(1):35-46. PubMed ID: 2905622 [TBL] [Abstract][Full Text] [Related]
33. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583 [TBL] [Abstract][Full Text] [Related]
34. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216 [TBL] [Abstract][Full Text] [Related]
35. Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus. Ostock CY; Hallmark J; Palumbo N; Bhide N; Conti M; George JA; Bishop C Neuropharmacology; 2015 Aug; 95():215-25. PubMed ID: 25817388 [TBL] [Abstract][Full Text] [Related]
36. Modulation of catecholamine release by alpha 2-adrenoceptors and I1-imidazoline receptors in rat brain. Meana JJ; Herrera-Marschitz M; Goiny M; Silveira R Brain Res; 1997 Jan; 744(2):216-26. PubMed ID: 9027381 [TBL] [Abstract][Full Text] [Related]
37. The pharmaco-ontogeny of the paraventricular alpha 2-noradrenergic receptor system mediating norepinephrine-induced feeding in the rat. Capuano CA; Leibowitz SF; Barr GA Brain Res Dev Brain Res; 1992 Jul; 68(1):67-74. PubMed ID: 1325877 [TBL] [Abstract][Full Text] [Related]